Alpha Crest Capital Management LLC Cytokinetics Inc Transaction History

Alpha Crest Capital Management LLC

  • $0
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$38.54 - $54.52 $222,106 - $314,198
5,763 New
5,763 $279,000
Q3 2021

Nov 10, 2021
SELL
$18.54 - $35.74 $369,112 - $711,547
-19,909 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$19.79 - $26.99 $393,999 - $537,343
19,909 New
19,909 $394,000

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email